Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kalle Jokelainen is active.

Publication


Featured researches published by Kalle Jokelainen.


Life Sciences | 1997

Inhibition of bacteriocolonic pathway for ethanol oxidation by ciprofloxacin in rats.

Kalle Jokelainen; T. Nosova; T. Koivisto; S. Väkeväinen; H. Jousimies-Somer; R. Heine; M. Salaspuro

Many colonic bacteria possess marked alcohol dehydrogenase (ADH) activity and are capable of oxidizing ethanol to acetaldehyde both in vitro and in vivo. We have recently shown that part of ingested ethanol is metabolized to acetaldehyde in the colon during normal alcohol metabolism. To assess the contribution of this bacteriocolonic pathway for ethanol oxidation to total ethanol metabolism, the elimination rate of ethanol, faecal aerobic flora and faecal ADH activity were determined in rats before and after the treatment with ciprofloxacin (200 mg/kg/day) for four days. Ciprofloxacin treatment decreased ethanol elimination rate from 310+/-9 to 282+/-13 mg/kg/h (mean+/-SE; p<0.02), markedly reduced faecal aerobic flora, and also lowered faecal ADH activity from 63+/-17 to 17+/-7 nmol/min/mg faeces (p<0.05). Neither hepatic ADH nor microsomal ethanol oxidizing system activities were affected by the ciprofloxacin treatment. On the contrary, an acute intraperitoneal dose of ciprofloxacin had no effect on the rate of ethanol elimination. These results support the significant role of the bacteriocolonic pathway in total ethanol elimination, and open a new, microbiological, perspective for studies on ethanol metabolism and pathogenesis of alcohol related organ damages.


Drug and Alcohol Dependence | 1990

The effects of moderate drinking and abstinence on serum and urinary β-hexosaminidase levels

Päivi Kärkkäinen; Kalle Jokelainen; Risto Roine; Antti Suokas; Mikko Salaspuro

The effects of moderate alcohol intake on serum (SHEX)- and urinary beta-hexosaminidase (UHEX) were studied in ten healthy volunteers, who ingested 60 g of 100% ethanol daily for 10 days. The drinking period was preceded and followed by an abstinence period. Moderate drinking and abstinence were rapidly and significantly reflected on SHEX, while UHEX levels did not change significantly during the study. Gramma-glutamyl transpeptidase (GGT), aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) decreased during the first abstinence period (P less than 0.05), but stayed thereafter at a constant level. It is concluded that SHEX may better reflect recent alcohol consumption than UHEX, GGT, ASAT or ALAT.


Alcoholism: Clinical and Experimental Research | 2003

Lactulose Reduces Intracolonic Acetaldehyde Concentration and Ethanol Elimination Rate in Rats

Sémia H. Zidi; Klas Linderborg; Satu Väkeväinen; Mikko Salaspuro; Kalle Jokelainen

BACKGROUND Normal colonic bacteria possessing alcohol dehydrogenase activity can oxidize ethanol to acetaldehyde. Acetaldehyde recently has been shown to be a local carcinogen in humans. The aim of the study was to examine the effect of lactulose feeding on fecal and cecal pH, intracolonic acetaldehyde concentration, and total ethanol elimination rate in rats. METHODS Sixty Wistar rats were divided into four groups. Groups 2 and 4 received lactulose daily (11 g/kg body weight for 14 days). On days 7 and 14, groups 1 and 2 received ethanol (1.5 g/kg body weight) intraperitoneally, whereas groups 3 and 4 received saline. RESULTS Fecal and cecal pH values decreased significantly after lactulose treatment compared with the controls. Lactulose feeding reduced the total ethanol elimination rate by 13.8% (257 +/- 0.008 mg/kg/hr vs. 298 +/- 0.003 mg/kg/hr, p < 0.001) and the intracecal acetaldehyde concentration by 66.2% after ethanol (49 +/- 29 microM vs. 145 +/- 47 microM, p = 0.03) compared with the controls. CONCLUSION Lactulose feeding to rats significantly reduces ethanol elimination rate and intraluminal acetaldehyde concentration in the colon after ethanol administration. This prebiotic thus could be used as an effective agent to block the microbial production of carcinogenic acetaldehyde in the large intestine.


Carcinogenesis | 1997

High acetaldehyde levels in saliva after ethanol consumption: methodological aspects and pathogenetic implications.

Nils Homann; Hannele Jousimies-Somer; Kalle Jokelainen; Riitta Heine; Mikko Salaspuro


American Journal of Physiology-gastrointestinal and Liver Physiology | 2003

Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-κB-dependent genes

Amin A. Nanji; Kalle Jokelainen; Gl Tipoe; Amir Rahemtulla; Peter Thomas; Andrew J. Dannenberg


Journal of the National Cancer Institute | 1997

Effects of Acetaldehyde on Cell Regeneration and Differentiation of the Upper Gastrointestinal Tract Mucosa

Nils Homann; Tiina Koivisto; Tatiana Nosova; Kalle Jokelainen; Mikko Salaspuro; Päivi Kärkkäinen


American Journal of Physiology-gastrointestinal and Liver Physiology | 2001

Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines.

Amin A. Nanji; Kalle Jokelainen; Maryam Fotouhinia; Amir Rahemtulla; Peter Thomas; Gl Tipoe; Grace L. Su; Andrew J. Dannenberg


Journal of Pharmacology and Experimental Therapeutics | 2004

Alcoholic Liver Injury in the Rat Is Associated with Reduced Expression of Peroxisome Proliferator-α (PPARα)-Regulated Genes and Is Ameliorated by PPARα Activation

Amin A. Nanji; Andrew J. Dannenberg; Kalle Jokelainen; Nathan M. Bass


Alcoholism: Clinical and Experimental Research | 1996

In vitro alcohol dehydrogenase-mediated acetaldehyde production by aerobic bacteria representing the normal colonic flora in man

Kalle Jokelainen; A. Siitonen; Hannele Jousimies-Somer; T. Nosova; R. Heine; Mikko Salaspuro


Journal of Pharmacology and Experimental Therapeutics | 2001

Dietary Saturated Fatty Acids Reverse Inflammatory and Fibrotic Changes in Rat Liver Despite Continued Ethanol Administration

Amin A. Nanji; Kalle Jokelainen; Gl Tipoe; Amir Rahemtulla; Andrew J. Dannenberg

Collaboration


Dive into the Kalle Jokelainen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amir Rahemtulla

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gl Tipoe

University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

T. Nosova

Helsinki University Central Hospital

View shared research outputs
Top Co-Authors

Avatar

Peter Thomas

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge